S&P 500

5.222,68

0,16%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Biocept Inc (BIOC)
Biocept Inc (BIOC) Notícias

BIOC

Biocept (BIOC)

Biocept Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:BIOC

1 2 3 4 5 6 7 8 9 10 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
20/10/2023	07:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOC	Biocept Inc
21/09/2023	09:00	Business Wire	Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases	NASDAQ:BIOC	Biocept Inc
08/09/2023	09:00	Business Wire	Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics	NASDAQ:BIOC	Biocept Inc
05/09/2023	09:00	Business Wire	Biocept to Participate in the H.C. Wainwright Global Investment Conference	NASDAQ:BIOC	Biocept Inc
25/08/2023	09:00	Business Wire	Biocept to Hold Business Update Conference Call on August 30, 2023	NASDAQ:BIOC	Biocept Inc
14/08/2023	17:05	Business Wire	Biocept Reports Second Quarter 2023 Financial Results	NASDAQ:BIOC	Biocept Inc
14/08/2023	09:00	Business Wire	Biocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference	NASDAQ:BIOC	Biocept Inc
13/07/2023	19:15	Business Wire	Biocept Announces the Passing of Board Chair M. Faye Wilson	NASDAQ:BIOC	Biocept Inc
21/06/2023	17:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIOC	Biocept Inc
20/06/2023	20:10	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:BIOC	Biocept Inc
20/06/2023	17:15	Business Wire	Biocept Names Antonino Morales as President and Chief Executive Officer	NASDAQ:BIOC	Biocept Inc
14/06/2023	17:05	Business Wire	Biocept to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20, 2023	NASDAQ:BIOC	Biocept Inc
05/06/2023	09:00	Business Wire	Scientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept’s CNSide™ Versus Cytology	NASDAQ:BIOC	Biocept Inc
25/05/2023	07:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BIOC	Biocept Inc
24/05/2023	21:39	Business Wire	Biocept Announces Pricing of $5.0 Million Underwritten Public Offering	NASDAQ:BIOC	Biocept Inc
23/05/2023	09:18	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:BIOC	Biocept Inc
17/05/2023	09:00	Business Wire	Biocept Announces One-for-Thirty Reverse Stock Split	NASDAQ:BIOC	Biocept Inc
10/05/2023	17:05	Business Wire	Biocept Reports First Quarter 2023 Financial Results	NASDAQ:BIOC	Biocept Inc
21/04/2023	09:31	Edgar (US Regulatory)	Revised Proxy Soliciting Materials (definitive) (defr14a)	NASDAQ:BIOC	Biocept Inc
20/04/2023	17:07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BIOC	Biocept Inc
17/04/2023	17:10	Business Wire	Biocept Reports 2022 Financial Results	NASDAQ:BIOC	Biocept Inc
17/04/2023	17:04	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	NASDAQ:BIOC	Biocept Inc
03/04/2023	09:01	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:BIOC	Biocept Inc
24/03/2023	09:00	Business Wire	Enrollment Begins in FORESEE Clinical Trial Using Biocept’s CNSide™ to Evaluate Patients with Leptomeningeal Metastases	NASDAQ:BIOC	Biocept Inc
01/03/2023	10:00	Business Wire	Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:BIOC	Biocept Inc
06/01/2023	08:55	Business Wire	Biocept to Explore Strategic Alternatives and Implement Restructuring Plan	NASDAQ:BIOC	Biocept Inc
21/11/2022	18:12	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOC	Biocept Inc
21/11/2022	18:05	Business Wire	Biocept Reports Third Quarter 2022 Financial Results	NASDAQ:BIOC	Biocept Inc
18/11/2022	10:00	Business Wire	Biocept Appoints Financial Executive Quyen Dao-Haddock to its Board of Directors	NASDAQ:BIOC	Biocept Inc
16/11/2022	10:00	Business Wire	Biocept Announces Participation in an Investigator-Initiated Study to Better Understand the Development and Progression of Metastatic Breast Cancer to the Central Nervous System	NASDAQ:BIOC	Biocept Inc